Key Takeaways

• Capsum has acquired KKT Labs and appointed its founder, Krupa Koestline, as CEO for U.S. operations to drive growth.
• The company anticipates U.S. revenue could reach between $70 million and $100 million in the next four to five years.
• Koestline aims to cater to indie beauty brands while expanding into new product lines beyond skincare and makeup.

Growth Strategy in the U.S. Market

French contract manufacturer Capsum has recently acquired KKT Labs, a consultancy specializing in beauty product development. Founder Krupa Koestline has been appointed as the CEO of Capsum’s U.S. operations, signaling a strategic move to bolster the company’s presence in the American market. While specific financial terms of the acquisition remain undisclosed, Capsum’s CEO, Sébastien Bardon, believes there is potential for the company to quadruple its U.S. revenue, targeting $70 million to $100 million over the next four to five years.

Capsum has laid the groundwork for this expansion by establishing a solar-powered manufacturing facility in Austin, which spans 120,000 square feet. The company has continued to thrive globally, reporting around 70 million euros (approximately $80 million) in revenue last year, with promising year-over-year growth due to its innovative use of microfluidics technology.

Koestline anticipates that Capsum can facilitate the development of unique products tailored to brands, steering away from standardized offerings. She emphasizes the company’s strength in creating differentiated products through microfluidics, which has so far predominantly served the skincare and hybrid makeup sectors. Koestline envisions expanding product lines to include body care, hair care, and sun care, fostering a new generation of beauty that leverages proprietary technology.

Capsum was founded in 2008 by scientists including Bardon, with the aim of revolutionizing cosmetics formulation through precise liquid control. Today, the company holds over 120 patents, employs 300 people, and has reported a steady 17% growth rate in recent years, with notable clients like CoverGirl and Meaningful Beauty.

In recent years, private equity interest has surged in the beauty manufacturing sector, prompting Capsum to explore potential partnerships. Bardon expects to finalize such strategic agreements within months. The acquisition of KKT Labs complements Capsum’s expertise in microfluidics with Koestline’s background in biotech and product innovation.

Founded in Orlando in 2020, KKT Labs initially catered to emerging clean beauty brands. The company has since established connections with about 50 clients, including prominent names like Kopari and Caldera Lab, reporting a 40% business increase in Q1 compared to the previous year. The move to integrate with Capsum will retain the existing KKT Labs team while enhancing operational capabilities in Austin.

Koestline, committed to supporting indie beauty brands, recognizes the challenges faced by smaller firms in the manufacturing landscape. She aims to deliver enhanced transparency and service options, as Capsum’s minimum order requirements are considered on a case-by-case basis.

The swift negotiation between Koestline and Bardon began as Koestline solicited investments for her firm. However, Bardon determined that acquiring KKT Labs would be a more effective strategy for accelerating growth. Capsum has previously explored investment in various startups focused on innovation within the beauty sector.

Looking ahead, Bardon outlines ambitious plans for Capsum, aiming for $200 million in revenue and expanding further into markets in China, Korea, and Japan. This expansion aligns with global trends as beauty brands seek to secure their supply chains in major regions. As Capsum continues to evolve, its dual focus on technological advancement and strategic growth positions it for significant impact in the beauty industry.

The content above is a summary. For more details, see the source article.